Oxidation of intramyocellular lipids is dependent on mitochondrial function and the availability of extracellular fatty acids

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 1, 2010, Pages

  Corpeleijn, Eva ^a   Hessvik, Nina P ^b   Bakke, Siril S ^b   Levin, Klaus ^c   Blaak, Ellen E ^a   Thoresen, G Hege ^b   Gaster, Michael ^c   Rustan, Arild C ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Lipid overflow; Lipid oxidation; Metabolic flexibility; Mitochondria

Indexed keywords

CARBON DIOXIDE; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; FATTY ACID; GLUCOSE; LIPID; OLEIC ACID;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID OXIDATION; LIPID STORAGE; LIPOLYSIS; MITOCHONDRION; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY QUOTIENT;

ADULT; CARBONYL CYANIDE P-TRIFLUOROMETHOXYPHENYLHYDRAZONE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; GLUCOSE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OBESITY; OLEIC ACID; STATISTICS, NONPARAMETRIC; UNCOUPLING AGENTS;

EID: 77953470349     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00187.2010     Document Type: Article

References (43)

1. Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53: 25-31, 2004. (Pubitemid 38044694)
2. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609-616, 1975.
3. Blaak EE. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 63: 323-330, 2004.
4. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. β-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol Endocrinol Metab 267: E316-E322, 1994.
5. Blaak EE, Wolffenbuttel BH, Saris WH, Pelsers MM, Wagenmakers AJ. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects. J Clin Endocrinol Metab 86: 1638-1644, 2001. (Pubitemid 32374916)
6. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612-1617, 2001. (Pubitemid 33639602)
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, Distefano A, Hwang YJ, Reznick RM, Codella R, Zhang D, Cline GW, Wakil SJ, Shulman GI. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 104: 16480-16485, 2007.
9. Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 16: 1025-1032, 2008.
10. Corpeleijn E, Saris WH, Blaak EE. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev 10: 178-193, 2009.
11. Corpeleijn E, van der Kallen CJ, Kruijshoop M, Magagnin MG, de Bruin TW, Feskens EJ, Saris WH, Blaak EE. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance. Diabet Med 23: 907-911, 2006. (Pubitemid 44141081)
12. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279: E554-E560, 2000.
13. Gaster M. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochem Biophys Res Commun 382: 766-770, 2009.
14. Gaster M. Reduced TCA flux in diabetic myotubes: a governing influence on the diabetic phenotype? Biochem Biophys Res Commun 387: 651-655, 2009.
15. Gaster M, Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim Biophys Acta 1761: 100-110, 2006.
16. Gaster M, Beck-Nielsen H, Schrøder HD. Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 109: 726-734, 2001.
17. Gaster M, Kristensen SR, Beck-Nielsen H, Schrøder HD. A cellular model system of differentiated human myotubes. APMIS 109: 735-744, 2001. (Pubitemid 34015455)
18. Gaster M, Petersen I, Højlund K, Poulsen P, Beck-Nielsen H. The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 51: 921-927, 2002. (Pubitemid 34438332)
19. Gaster M, Rustan AC, Aas V, Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 53: 542-548, 2004. (Pubitemid 38270621)
20. Gaster M, Rustan AC, Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 54: 648-656, 2005. (Pubitemid 40322066)
21. Højlund K, Frystyk J, Levin K, Flyvbjerg A, Wojtaszewski JF, Beck-Nielsen H. Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes. Diabetologia 49: 1283-1291, 2006.
22. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011, 2002.
23. Jocken JW, Blaak EE. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol Behav 94: 219-230, 2008.
24. Katterle Y, Keipert S, Hof J, Klaus S. Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1. Physiol Genomics 32: 352-359, 2008. (Pubitemid 351328558)
25. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
26. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50: 2548-2554, 2001. (Pubitemid 33642773)
27. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, Pypaert M, Shulman GI. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115: 3587-3593, 2005. (Pubitemid 43121847)
28. Moro C, Bajpeyi S, Smith SR. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 294: E203-E213, 2008.
29. Ortenblad N, Mogensen M, Petersen I, Hojlund K, Levin K, Sahlin K, Beck-Nielsen H, Gaster M. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect. Biochim Biophys Acta 1741: 206-214, 2005.
30. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100: 8466-8471, 2003.
31. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
32. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Moonen-Kornips E, Schaart G, Mustard KJ, Hardie DG, Saris WH, Nicolay K, Schrauwen P. Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 13: 2088-2094, 2005.
33. Schrauwen P, van Marken Lichtenbelt WD, Saris WH, Westerterp KR. Changes in fat oxidation in response to a high-fat diet. Am J Clin Nutr 66: 276-282, 1997.
34. Seidell JC, Muller DC, Sorkin JD, Andres R. Fasting respiratory exchange ratio and resting metabolic rate as predictors of weight gain: the Baltimore Longitudinal Study on Aging. Int J Obes Relat Metab Disord 16: 667-674, 1992.
35. Stellingwerff T, Boon H, Jonkers RA, Senden JM, Spriet LL, Koopman R, van Loon LJ. Significant intramyocellular lipid use during prolonged cycling in endurance-trained males as assessed by three different methodologies. Am J Physiol Endocrinol Metab 292: E1715-E1723, 2007.
36. Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab 89: 1301-1311, 2004.
37. Ukropcova B, McNeil M, Sereda O, de Jonge L, Xie H, Bray GA, Smith SR. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest 115: 1934-1941, 2005.
38. van Loon LJ, Manders RJ, Koopman R, Kaastra B, Stegen JH, Gijsen AP, Saris WH, Keizer HA. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients. Diabetologia 48: 2097-2107, 2005. (Pubitemid 41416922)
39. Watt MJ, Heigenhauser GJ, O'Neill M, Spriet LL. Hormone-sensitive lipase activity and fatty acyl-CoA content in human skeletal muscle during prolonged exercise. J Appl Physiol 95: 314-321, 2003.
40. Wensaas AJ, Rustan AC, Just M, Berge RK, Drevon CA, Gaster M. Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 58: 527-535, 2009.
41. Wensaas AJ, Rustan AC, Lövstedt K, Kull B, Wikström S, Drevon CA, Hallén S. Cell-based multiwell assays for the detection of substrate accumulation and oxidation. J Lipid Res 48: 961-967, 2007.
42. Wicklmayr M, Dietze G, Rett K, Mehnert H. Evidence for a substrate regulation of triglyceride lipolysis in human skeletal muscle. Horm Metab Res 17: 471-475, 1985.
43. Zurlo F, Lillioja S, Esposito-Del Puente A, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogardus C, Ravussin E. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol Endocrinol Metab 259: E650-E657, 1990. (Pubitemid 20385711)